Pacientes diabéticos sin cobertura de salud: Utilización de medicamentos, adherencia y complicaciones derivadas de su patología de base / Diabetic patients without health coverage: drug use, adherence and complications arising from their underlying disease

RESUMEN

Objetivo: realizar un Estudio de Utilización de Medicamentos de los pacientes diabéticos atendidos en el Hospital Josefina Prieur (HJP) de la ciudad de Villa Allende (Córdoba, Argentina), determinar consumo de medicamentos antidiabéticos, grado de adherencia al tratamiento y pacientes afectados por complicaciones derivadas de la diabetes.Método: Estudio observacional, descriptivo y transversal, sobre pacientes diabéticos atendidos en el HJP que pertenecen al Programa Córdoba Diabetes (ProCorDia) durante los meses de Mayo a Diciembre de 2011.Conclusiones: Del total de medicamentos antidiabéticos dispensados, el 40,50% correspondió al subgrupo A10B (hipoglucemiantes orales) y el 59,50% al subgrupo A10A (Insulinas). Se observó una buena adherencia al tratamiento Pacientes diabéticos sin cobeRtuRa de salud utilización de medicamentos, adheRencia y comPlicaciones deRivadas de su Patología de base Recibido 23 de enero de 2013. Aprobado 23 de mayo de 2013.

ABSTRACT

Objective: To carry out a drug usage study with diabetic patients treated at Josefina Prieur Hospital (HJP) Villa Allende city (Córdoba, Argentina) to determine anti-diabetic drug consumption, degree of treatment adherence, and amount of patients with complications arising from diabetes.Method: Observational, descriptive, cross-sectional study carried out on diabetic patients treated at the HJP belonging to the program “Programa Córdoba Diabetes” (ProCorDia), from May to December 2011. Drug consumption was determined in DDDs per 1000 inhabitants per day. Adherence was defined by the number of drug provisions for each patient during eight months. The presence of complications was obtained from records of drug delivery to patients receiving other medication besides anti-diabetic ones. Results: From 98 patients, 73 had some type of complication. The consumption of antidiabetic drugs in DDD per 1000 inhabitants per day was Regular Insulin 1.990, NPH Insulin 6.244, Glibenclamide 2.826, Gliclazide 0.281, Metformin 2.497.Conclusions: From all anti-diabetic drugs dispensed, 40.50% belonged to subgroup A10B (oral hypoglycemic agents) and 59.50% to subgroup A10A (insulin). Good adherence to drug therapy was observed (mean = 81.63%, mode = 100%). A 74.49% of patients presented complications.